Key facts
- Maneesh Pharmaceuticals’s last known valuation is $9.0M (Mar 2015).
- It has raised $2.9M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Hillcroft Investment, Relativity Investment Advisors.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Maneesh Pharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Maneesh Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maneesh Pharmaceuticals
Operator of a pharmaceutical company intended to advance medicine through research and development and develop drugs across the globe. The company offers creams, ointments, gels, lotions, hormone and beta-lactam products, sachet and granules, dietary supplements, and anti-tuberculosis drugs, enabling clients to obtain well-researched, quality products.
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 1975
- Employees
- 246
- Website
- maneeshpharma.com/
- Ownership
- Privately Held (backing)
Maneesh Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maneesh Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maneesh Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.